Yahoo
OTC Markets OTCQB - Delayed Quote USD

PreveCeutical Medical Inc. (PRVCF)

0.0155 +0.0035 (+29.17%)
At close: November 4 at 4:00:00 PM EST
Chart Range Bar
Loading chart for PRVCF
  • Previous Close 0.0120
  • Open 0.0120
  • Bid 0.0109 x 23400000
  • Ask 0.0183 x 1000000
  • Day's Range 0.0120 - 0.0120
  • 52 Week Range 0.0037 - 0.0279
  • Volume 16,000
  • Avg. Volume 32,461
  • Market Cap (intraday) 9.892M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson's disease; develops cannabinoid-based nose-to-brain delivery system for the relief of a various ailments, including pain, inflammation, seizures, and neurological disorders; peptide library synthesis, pharmacological evaluation, alongside pharmacokinetic assessment, and determinations in animal models of pain and inflammation; and non-addictive analgesic peptides for pain management. It also involved in licensing, branding, and marketing nutraceutical and wellness products; Sol-Gel platform; and peptide program. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.

www.preveceutical.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

PRVCF
6.00%
S&P/TSX Composite index (^GSPTSE)
11.73%

1-Year Return

PRVCF
36.73%
S&P/TSX Composite index (^GSPTSE)
19.57%

3-Year Return

PRVCF
3.33%
S&P/TSX Composite index (^GSPTSE)
79.60%

5-Year Return

PRVCF
9.88%
S&P/TSX Composite index (^GSPTSE)
65.95%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -145.32%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -689.28k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35.66k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.59M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: